All In Biotech

Free tool

FAERS Monitor: Magnesium Sulfate In Plastic Container

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020309 or its brand name (Magnesium Sulfate In Plastic Container, Magnesium Sulfate). Reports on generic versions are filed under their own applications.

Reports

17

Serious

13

76% of reports

Hospitalization

11

Death reported

1

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • burkholderia test positive8
  • endotracheal intubation5
  • dyspnoea4
  • covid-193
  • no adverse event3
  • respiratory rate decreased3
  • extrapyramidal disorder2
  • respiratory failure2
  • therapeutic product effect increased2
  • tremor2
  • acute kidney injury1
  • acute respiratory failure1
  • alcoholic pancreatitis1
  • atrial fibrillation1
  • bacterial infection1

Reports by year received

View as table
YearReports
20191
20212
202213
20241

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,142 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
burkholderia test positiveSignal885412.349971.3561,799
alcoholic pancreatitis16383.9948.51,587
endotracheal intubationSignal52210.81057.68,930
therapeutic product effect increased22129.8578.62,389
respiratory rate decreasedSignal31182.9423.32,457
extrapyramidal disorder299.727.1109
bacterial infection166.39.916
acute respiratory failure164.39.615
respiratory failure233.99.235
covid-19Signal321.27.640
no adverse eventSignal320.57.338
tremor214.94.114
atrial fibrillation112.71.92
dyspnoeaSignal48.73.721
acute kidney injury18.11.21

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.